Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Dec 9, 2011

NEW YORK (GenomeWeb News) – TrovaGene this week announced that it has named Antonius Schuh as CEO. Schuh previously served as chairman and CEO of Sorrento Therapeutics. He also has served as founding CEO of AviaraDx (now operating as BioTheranostics under parent company BioMérieux). Prior to that, he served as CEO of Arcturus, and president and CEO of Sequenom.

BioNano Genomics has hired Garth Monroe as CFO, the company said this week. Prior to joining BioNano Genomics, Monroe was CFO of medical device firm Epocal (now part of Alere). He previously served as a station manager for JetBlue and financial analyst at United Technologies.

Lu Wang has become program director of the National Human Genome Research Institute's new Mendelian Disorders Genome Centers program. Brad Ozenberger, NHGRI's program director for Genomic Medicine, and Jean McEwen, program director for the Ethical, Legal, and Social Implications program, will oversee the institute's new Clinical Sequencing Exploratory Research Projects initiative.

Scienion has tapped Craig Cardella to manage its newly founded US subsidiary. Cardella previously was the East Coast sales manager for Matrical Bioscience.

Grove Instruments, a medical device company, said that it has appointed Craig Mello to its board of directors. Mello conducted pioneering research on RNAi, and won the Nobel Prize with collaborator Andy Fire for their work on the gene-silencing technology in 2006.

PositiveID has appointed William Caragol as chairman of the board. Caragol has been CEO since August 2011, president since 2007, and a member of the board since November 2009.

PrimeraDx this week announced that it has appointed Leroy Hood to its scientific advisory board. Hood has helped found several research and commercial enterprises, including Applied Biosystems (now part of Life Technologies), Amgen, and the Institute for Systems Biology, where he currently holds the position of president.

Masayasu Nomura, a molecular biologist who conducted early studies of ribosomes at the University of Wisconsin-Madison and at the University of California-Irvine, died on Nov. 19 at the age of 84, UW-Madison said this week. Nomura was known for his efforts using tools that now would be considered primitive to disassemble and reassemble the ribosome in a test tube. He was a researcher for two decades at UW-Madison until 1984, when he became the Grace Bell Professor of Biological Chemistry at UC- Irvine.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.